News
Read more
SOMAÍ Partners with SHERBINSKIS and BOUTIQ
A New Era for Medical Cannabis: SOMAÍ Teams Up with Iconic California Brands SHERBINSKIS and BOUTIQ for Europe and Australia...
Read more
Ireland Could Make Great Cannabis Policy: Examining the Past to Look Forward
Access to safe and controlled cannabis for the Irish people is being decided upon in 2025. Watching a country make...
Read more
Product Dumping, White Labels, and Conflicts of Interest Lead to Global Cannabis Price Catastrophe
2025 has kicked off fast and furious for the global cannabis industry as volumes increase and more countries come online...
Read more
The Rise of Multi-Country Operators: Somai Targets 20 Countries by Year End
Multi-state operators, or MSO’s, have long represented the biggest and most influential cannabis players in North America. Yet, as that...
Read more
The Shift Toward Recognised Brands in Medical Cannabis
For years, medical cannabis has been treated as a commodity, with little emphasis on brand differentiation. However, as the market...
Read more
Eyes on Thailand in the Global Medical Cannabis Scene: SOMAÍ and Cali Dior Lead the Revolution
Global medical cannabis markets are exploding, and the patients exploring cannabis as an alternative therapy are more diverse than ever....
Read more
Q4 2024: Global Medical Cannabis Continues To Soar
The global cannabis industry saw an incredible end to 2024. Q4 2024 showed that the international medical cannabis explosion is...
Read more
SOMAÍ Joins Forces with Dascoli to Advance Swiss Medical Cannabis Market
Expanding its global footprint, SOMAÍ continues its European growth with a Swiss market entry through a strategic partnership with Dascoli...
Read more
The lobsterpot podcast S.4 EP. 1 wih Michael Sassano
SOMAÍ’s CEO, Michael Sassan, joins The Lobsterpot Podcast for an in-depth conversation on the future of Europe’s cannabis markets as...
Read more
U.S.-style cannabis dispensaries are sweeping global medical markets
Medical cannabis markets around the world are starting to show signs of early United States and Canadian-style progressions. Consumer flower...
Read more
2025 Cannabis Predictions: The Global Medical Cannabis Explosion Continues
2025 is poised for a massive explosion in the global medical cannabis market. Many politicians and regulators have been grappling...
Read more
SOMAÍ Pharmaceuticals and PACCAN Join Forces to Transform Medicinal Cannabis in Asia and Beyond
SOMAÍ Pharmaceuticals partnered with Pacific Cannovation Company Limited (PACCAN) to transform Thailand into a global hub for high-quality medicinal cannabis...
Read more
SOMAÍ Pharmaceuticals Redefines Patients Experience with the Launch of Origins and Senses Lines
SOMAÍ Pharmaceuticals, a leading EU-GMP vertically integrated Multi-Country Operator (MCO) company, proudly announces the global launch of its Origins and...
Read more
Portugal em Direto – Maior Empresa Da Europa Está Em Portugal
RTP1 - Portugal em Direto about SOMAÍ Pharmaceuticals
Read more
Portugal é o “epicentro do cultivo e produção de canábis”, revela CEO da SOMAÍ Pharmaceuticals
Com uma das maiores infraestruturas para cultivo e produção de canábis, Portugal é o maior exportador europeu desta planta para...
Read more
Cannabis industry predictions 2025: Market trends
Although new states continue to implement medical and adult-use cannabis programs, sales have been declining in the early adopters of...
Read more
The Grünhorn and Canymed Edge: Introducing Germany to SOMAÍ Extracts
Germany is one of the fastest-growing global medical cannabis markets. Recent changes in cannabis legislation have allowed doctors to more...
Read more
Business of Cannabis: Podcast | Releaf x SOMAÍ Pharmaceuticals
Releaf Clinic and SOMAÍ Pharmaceuticals have joined forces to provide UK patients with the largest portfolio of cannabis-based medicinal products...
Read more
2025 Czechia Cannabis Predictions from Cannafest
Czechia has a population of roughly 11 million people, and cannabis has been decriminalized since 2010. As one of the earliest...
Read more
Público: Michael trouxe a experiência da cannabis medicinal do Nevada para o Carregado
Portugal já exportou este ano quase 19 toneladas de cannabis, sobretudo para a Alemanha. Em Outubro, existiam 37 entidades licenciadas...
Read more
Compounding the Issue: Germany’s Medical Cannabis Market Needs a New Approach
Germany has some of the most progressive cannabis rules in the global markets. The cannabis industry is celebrating decriminalization, which provides...
Read more
Michael Sassano: Spain finally opens access to medical cannabis
After three years of political delays, Spain has taken a big step toward starting what it promised in terms of...
Read more
The Good, the Bad, and the Profitable: Inside Germany’s EU-Leading Medical Cannabis Industry
The growth of the German medical cannabis market is poised to be highly profitable for the country. One billion euros...
Read more
The AusCannaPodcast S2 | E8 with Michael Sassano
In this episode of the AusCannaPodcast, Christina Mc Mullan sits down with Michael Sassano, CEO and Chairman of SOMAI Pharmaceuticals,...
Read more
Poland’s Path to Cannabis: Two Companies Meeting Market Demands
Poland is the fastest-growing new cannabis market in the entire global medical space. Not only is the extracts market growing...
Read more
SOMAÍ Pharmaceuticals e Universidade Lusófona colaboram em publicação científica sobre o efeito ‘entourage’
A indústria da canábis medicinal continua a evoluir, com a investigação a abrir caminho para aplicações terapêuticas inovadoras. A SOMAÍ Pharmaceuticals,...
Read more
Two Cannabis Vertical Powerhouses Partner to Optimize Patient Experience
When two great companies pair to create the best patient experience possible, the global CBPM industry must take notes. Ultimately,...
Read more
Michael Sassano: “Portugal is the epicentre of cannabis cultivation and production. This is a place that will thrive”
Michael Sassano’s main goal at SOMAÍ is to produce the most advanced products with the most innovative administration routes, to...
Read more
European Cannabis Q3 2024 Quarterly Update
“WOW” is the only word to describe the excitement buzzing around the European cannabis community. The cannabis markets in Europe...
Read more
Impairment Vs Presence Of Cannabis: The International Cannabis Driving Debate Continues
Around the world, the debate continues about how to quantify the presence of cannabis in an individual’s system and how...
Read more
Give and Toke: Excitement in Global Markets w/ Michael Sassano (SOMAÍ Pharmaceuticals)
Listen to the latest episode of the Give and Toke podcast, which elevates the conversation about cannabis to a higher...
Read more
Drug Science: What is the UK medical cannabis industry looking like in 2024?
We are 6 years on from legalisation of cannabis-based medical products in the UK and although many patients have now...
Read more
EU Medical Cannabis Meets Recreational Choice: A New Era in European Preference
Europe has been one of the most interesting cannabis markets to watch develop: What was a pure medical cannabis market has...
Read more
SOMAÍ Pharmaceuticals Announces Partnership with Releaf Clinic to Bring Innovative Cannabis Solutions to UK Patients
This collaboration marks the synergy of two vertically integrated fast-growing companies. SOMAÍ Pharmaceuticals is proud to announce a strategic partnership...
Read more
Innovations in Cannabis Extracts Entice New Demographics
Interesting trends emerge when we examine the largest extract markets in the global cannabis industry. These trends suggest that innovations...
Read more
SOMAÍ Pharmaceuticals Launches in Ireland, Offering the Broadest Range of Cannabis-Based Medicines to Patients
SOMAÍ Pharmaceuticals ("SOMAÍ"), a leading EU-GMP vertically integrated Multi-Country Operator (MCO) company with a global footprint of distribution for the...
Read more
What Does the Future Hold for UK Cannabis?
After a recent conversation with Pierre van Weperen of Grow Group PLC and Grow Pharma, his vision of the United Kingdom’s...
Read more
EU verticals create new European MCOs: Multi-Country Operators
New European MCOs: Multi-Country Operators European cannabis markets are heating up, and virtually every country is buzzing about regulatory change...
Read more
The Best Global Cannabis Markets By Country 2023-2024
The global cannabis universe continues to expand rapidly after the United States Department of Health and Human Services (HHS) report, Germany’s removal...
Read more
Global Cannabis: Michael Sassano, CEO and Founder at Somai Pharmaceuticals (AltMed Ep.117)
Watch the latest AltMed podcast, in which Michael Sassano and Andrew Dowling, AltMed's co-founder, discuss different aspects of the global...
Read more
The battle for Australian-grown cannabis: quality vs global price wars
There is a buzz around Australia about “Made in Australia” products, including cannabis. Every country should be proud of its...
Read more
Cosma S.A. and SOMAÍ Pharmaceuticals partner to Revolutionize Poland with the most Innovative Cannabis-Based Solutions
LISBON, PORTUGAL, August 29, 2024 - Cosma S.A., a leader in cannabis-based pharmaceutical advancements, and SOMAÍ Pharmaceuticals, a fully vertically...
Read more
Hanf Journal: Interview mit Michael Sassano, CEO von SOMAÍ Pharmaceuticals
Cannabis-Extrakte haben sich als vielversprechendes Therapeutikum in der modernen Medizin etabliert. Allerdings werden viele Anwenderinnen und Anwender vom Geschmack abgeschreckt,...
Read more
ICBC News: Legal Global Cannabis Products Are Becoming More Diverse
As the legal cannabis industry continues to expand to nearly every corner of the planet, the variety of products available...
Read more
What is Spain’s New Medical Cannabis Regulatory Framework?
Ultimately, patients deserve access to safer alternatives to current over-prescribed pharmaceutical medicines. Spain has become the latest large European country...
Read more
2024’s Hottest Global Medical Cannabis Market Trends
A massive dose of energy has jolted the global cannabis markets. The United States Department of Health and Human Services (HHS)...
Read more
European Cannabis Q2 2024 Quarterly Update
2024’s second quarter transpired strongly and predictably after the positive news of the 252-page United States Department of Health and Human...
Read more
CannaReporter: SOMAÍ’s Journey to Global Leadership in Cannabinoid Extracts
SOMAÍ Pharmaceuticals is a leading EU-GMP European vertically integrated Multi-Country Operator (MCO) company with a global footprint of distribution for...
Read more
Sassano: Why future EU medical cannabis branding is essential
Michael Sassano is a CEO and Chairman of the Board for SOMAÍ Pharmaceuticals, a leading EU-GMP European pharmaceutical and biotech...
Read more
SOMAÍ Pharmaceuticals Expands Its Most Comprehensive Medicinal Cannabis Portfolio With Launch of New Mint Oral Solutions Line
SOMAÍ Pharmaceuticals ("SOMAÍ"), a fully vertically integrated Multi-Country Operator (MCO) in the global medical cannabis markets, is proud to announce...
Read more
Financial Times: European cannabis companies start IPO planning as US considers looser rules
A number of European cannabis start-ups are planning to go public in New York to take advantage of a US...
Read more
Put Some Mint Terpenes In It
What is the first thing you do when you open a new bag of cannabis flower? You smell it! Cannabis...
Read more
Cannabiz: SOMAÍ Pharmaceuticals ‘keeps promise’ to deliver expanded product range
SOMAÍ Pharmaceuticals is rolling out a suite of new products in Australia as it aims to back up its pledge...
Read more
Germany Leads The Global Medical Cannabis Explosion
The entire cannabis community is abuzz with German legalization. Not only is this a massive windfall for cannabis producers around the...
Read more
A Comparison Of Legal And Illicit EU Cannabis Markets
Co-Authored by Michael Sassano and Callum Kellas The cannabis illicit market existed in all countries long before the legal markets...
Read more
Pillar 2: German Cannabis Legalization is Moving Forward Fast
As if 2024 didn’t give the global medical cannabis enough with a 252-page report from the United States Department of Health and...
Read more
European Cannabis Q1 2024 Quarterly Update
2024 ushered in one of the most reformatory changes that the global medical cannabis community has ever witnessed. The EU...
Read more
Business of Cannabis: Breaking Down Barriers to Medical Cannabis in the UK
UK medical cannabis patients are facing multiple challenges that are preventing the adoption of the legal market. From stigmatisation and...
Read more
Medical Cannabis Goes Global: Michael Sassano of SOMAÍ reflects on UK launch (GC S2E7)
https://www.youtube.com/watch?v=tObqvfLA5lo&t=9s&ab_channel=GrowConversations Discussing a range of topics, including Michaels's background in setting up medical cannabis cultivation facilities in the US, The...
Read more
Leading Canadian Cannabis Brand Ghost Drops Enters into an Agreement with SOMAÍ Group for Global Distribution
The partnership opportunely positions Ghost Drops and SOMAÍ Group to succeed in the EU, UK, and Australian Cannabis Markets LISBON,...
Read more
SOMAÍ Group, and its subsidiary, RPK Biopharma expand Cookies partnership to include Europe and the UK
SOMAÍ Group ("SOMAÍ") and its subsidiary, RPK Biopharma expanded their existing partnership with Cookies Creative Consulting & Promotions, Inc., a...
Read more
Cannabis Rescheduling: DEA’s Decision Marks a New Era for the Industry
The US Drug Enforcement Administration (DEA) is set to approve the rescheduling of cannabis in a move set to have...
Read more
The Medical Cannabis Explosion Just Got Real
The global cannabis trifecta has hit! The United States has finally rescheduled cannabis, moving it to Schedule III; the Department...
Read more
EU STARTUP NEWS: Reshaping EU’s Biopharma Industry: Is Cannabis the Future of Pharmaceutical Treatments?
While the boundaries of pharmaceuticals continue to expand with cutting-edge innovations, Lisbon-based company SOMAÍ Pharmaceuticals is trailblazing in the field...
Read more
Euronews: Portugal grows tonnes of medical cannabis for export but it remains out of reach for local patients
“We’re a global company and as countries develop, we plug into that. We are still waiting for Portugal but it's...
Read more
Japanese Cannabis Reform Is Almost Here
In November 2023, the Japanese Ministry of Health, Labor and Welfare (MHLW) was tasked with developing rules and standards for THC levels...
Read more
Assessing Thailand’s Massive Cannabis Market Reality
The Thai cannabis market is currently a full-blown recreational model, and it has exploded quicker than any market in legal...
Read more
The Global Medical Cannabis Explosion Is Coming
Based in Lisbon, Portugal, Somai Pharmaceuticals is a large-scale, GMP-certified manufacturer and global supplier of cannabis products used in pharmacological...
Read more
When it comes to access, the rest of the world should follow Australia’s example
The Australian medical cannabis industry may have its challenges, but its focus on affordable access and patient care make it...
Read more
The Surging Tides Of Global Medical Cannabis Markets
You may not see it or even hear about it but have no doubts: an enormous regulatory framework tsunami pushing...
Read more
SOMAÍ Pharmaceuticals Introduces UK to The Most Complete Cannabis-Based Product Portfolio Following a Distribution Deal
SOMAÍ Pharmaceuticals Signs Distribution Deal with Grow Pharma for UK’s Most Comprehensive Range of Cannabis-Based Medicines LISBON, PORTUGAL, March 12,...
Read more
SOMAÍ Pharmaceuticals brings innovative product portfolio to Australia
European medicinal cannabis manufacturing powerhouse SOMAÍ Pharmaceuticals is set to shake up the Australian market with a range of products...
Read more
SOMAÍ Pharmaceuticals brings innovative product portfolio to Australia
European medicinal cannabis manufacturing powerhouse SOMAÍ Pharmaceuticals is set to shake up the Australian market with a range of products...
Read more
Ukraine joins global cannabis community
Now that Ukrainian President Volodymyr Zelenskiy has signed a law opening access to medical cannabis, Ukraine has joined a list of...
Read more
European Cannabis Q4 2023 Quarterly Update
U.S. and German Events Steer International Cannabis in 2024 As 2023 ended, all eyes remained glued on the United States Schedule...
Read more
Don’t get caught on the hop by HLVd
As Hop Latent Viroid is discovered in Australian cannabis crops for the first time, SOMAÍ Pharmaceuticals founder, chairman, and CEO Michael Sassano shares advice...
Read more
SOMAÍ Pharmaceuticals Acquires RPK Biopharma (Holigen), Reinforcing Global Leading Position in Medicinal Cannabis Sector
This strategic acquisition enhances SOMAÍ's capacity with best-in-class cultivation, manufacturing, and distribution assets, making it one of the few verticals...
Read more
The Global Medical Cannabis Explosion is Imminent
Recently, I have become more optimistic about the global landscape of medical cannabis and the direction in which major regulatory...
Read more
2024 New Global Emerging Cannabis Markets Predictions
"As the entire cannabis world is abuzz and cannabis stocks are shooting through the roof with the potential United States...
Read more
Good or bad taste will make or break your cannabis product
When it comes to creating the ultimate cannabis brand, it’s all a matter of taste, says SOMAÍ Pharmaceuticals founder, chairman,...
Read more
SOMAÍ Pharmaceuticals Introducing the U.S. Award-Winning Airo Brand to European and Australian Markets
SOMAÍ Pharmaceuticals announces its partnership with AIRO BRANDS, a U.S. multi-state CPG company focused on proprietary cannabis products. LISBON, PORTUGAL,...
Read more
The Mary Jane Society Podcast: Michael Sassano On Europe’s Cannabis Market
SOMAÍ Pharmaceutical‘s CEO Michael Sassano explores why the bill is a double edged sword, marking positive progress on one hand, but...
Read more
US Cannabis Rescheduling Primed to Set Off a Global Cannabis Explosion
Written by Michael Sassano, CEO, Somai Pharmaceuticals. Published in Business of Cannabis. On January 12, the United States Department of Health and...
Read more
Looking to expand overseas? Here’s what you need to know
Cannabis has long been trending as a global product, providing regional players with the chance to expand into international markets. Somai...
Read more
Why 2024 Will Be the Best Year Yet for Cannabis Investment
Year over year, global cannabis revenues exceed expectations and now stand at an estimated $50 billion in global sales in...
Read more
How Australian Cannabis Brands Can Enter Europe
Cannabis has long been trending as a global product, providing regional players opportunities to reach outside their home countries and...
Read more
Ukraine Makes ‘Historic Decision’ to Legalise Medical Cannabis
“Ukraine is headed towards cannabis legalisation which will align themselves next to German cannabis reform. As pivotal as Ukraine is...
Read more
Ukraine Lawmakers Vote to Legalize Medical Marijuana
Ukraine’s parliament voted today to legalize medical marijuana. This vote comes after the war with Russia left thousands of people...
Read more
Ukraine Lawmakers Vote To Legalize Medical Cannabis
“Ukraine legalizing cannabis should be a signal to all countries that prohibit medicinal cannabis, that there are much worst things...
Read more
The Future of European Medical Cannabis Dispensaries
As Switzerland opens up its first cannabis dispensary, cannabis pharmacies in the European Union need to pay attention and look...
Read more
SOMAÍ Pharmaceuticals and Canify Announce Their Partnership to Introduce a Cannabinoid-Based Product Line in Germany
SOMAÍ Pharmaceuticals and Canify AG announce their strategic partnership to introduce a differentiated cannabinoid-based product line in Germany LISBON, PORTUGAL,...
Read more
SOMAÍ Pharmaceuticals Enters German Market with Strategic Partnerships Securing €10 Million 2-year Distribution Deal
SOMAÍ Pharmaceuticals announces two significant partnerships with Canymed GmbH and Grünhorn, as part of its entry into the German market....
Read more
SOMAÍ Pharmaceuticals is thrilled to partner with the groundbreaking medical cannabis study, T21
Launched in 2019 by Drug Science, and now over 4000 patients in, T21 is building the scientific evidence base for...
Read more
3 main contributors to the entourage effect for cannabis consumers to consider
There is much talk surrounding the "entourage effect" in the cannabis world. The entourage effect is the proposed idea that...
Read more
SOMAÍ Pharmaceuticals Signs Manufacturing Contract with Canna Forest
SOMAÍ Pharmaceuticals has signed a manufacturing agreement with Canna Forest to produce EU-GMP-certified extracted cannabis APIs and products at its...
Read more
Q3 2023 European And US Cannabis Update
In the new edition of the "Q3 2023 European And US Cannabis Update," SOMAÍ Pharmaceuticals Founder and CEO Michael Sassano...
Read more
Four things to know for properly dosing oral cannabis formulations
As oral cannabis solutions become more popular, Michael Sassano CEO and founder of SOMAÍ Pharmaceuticals, explains how to get the...
Read more
Why white-labelled EU cannabis brands will fail
The European Union and global markets have invited the next cannabis disaster by disguising asset-poor brands as distributors and clinics....
Read more
SOMAÍ Pharmaceuticals Makes ‘Significant Step Towards Revenue Generation’ As Portuguese Market Heats Up
Last month, Portugal’s government announced plans to establish a working group to explore the regulation of adult-use cannabis, with a...
Read more
What is Medicinal cannabis
Read more
What are the key components of medicinal cannabis?
Read more
What is the story behind Medicinal cannabis?
Read more
The endocannabinoid system
Read more
How does the endocannabinoid system work?
Read more
SOMAÍ Pharmaceuticals: recent developments in the eyes of Michael Sassano
SOMAÍ Pharmaceuticals is a large-scale manufacturer of cannabis products, focusing on the highest quality medical-grade uses. They separate and purify...
Read more
Cannabinoids and the endocannabinoid system
Read more
What does the medicinal cannabis landscape look like today?
Read more
SOMAÍ Pharmaceuticals Receives EU-GMP Certification and Raises €5 million
SOMAÍ Pharmaceuticals Unipessoal LDA, the largest European pharmaceutical cannabis product manufacturer, is pleased to announce that it has received authorisation...
Read more
Crude FECO Vs Distillate Extracts: What Do Consumers Really Prefer?
Last week, Germany took the first step towards wholesale cannabis legalisation after the federal cabinet waved through the long-awaited draft...
Read more
Australian medical cannabis prioritises growing patient access
The Australian cannabis market is one of the largest, fastest-growing and most robust medical industries outside North America. Australia’s market...
Read more
How cannabis could help manage the unmet need in endometriosis
Endometriosis is a chronic inflammatory disorder that affects 10% of all women between the ages of 12 and 80 years...
Read more
Evolving legislature
Read more
Safety of medicinal cannabis and its side effects
Read more
What is Next After the German House Passes Cannabis Reform?
Last week, Germany took the first step towards wholesale cannabis legalisation after the federal cabinet waved through the long-awaited draft...
Read more
Europe’s current and future cannabis distribution models
Cannabis distribution companies in Germany and England received much attention and funding in early 2022. The growing revenue led investors to...
Read more
What are the barriers facing Spanish medical cannabis access?
Following another recent disappointment for Spanish patients, Michael Sassano, CEO and founder of SOMAÍ Pharmaceuticals explores the barriers preventing the...
Read more
From investor to innovator: Michael Sassano’s journey with SOMAÍ Pharmaceuticals
In a recent chat with Michael Sassano, the CEO of SOMAÍ Pharmaceuticals, we delved into the intricacies of the cannabis...
Read more
SOMAÍ Pharmaceuticals has renewed the partnership with Lusófona University/CBIOS for formulation development
According to this partnership, Lusófona will develop lab-scale formulations and perform corresponding stability testing. The collaboration will also encompass "In...
Read more
Albania Officially Green Lights Medical and Industrial Cannabis Cultivation
Albania has become the latest European country to officially legalise the ‘cultivation and processing of the cannabis plant and the...
Read more
European Cannabis Q2 2023 Quarterly Update
Country access schemes were simmering in the EU. Pressure continues to build from patients and advocates to increase access to...
Read more
WHAT IS THE CANNABIS EDGE IN GERMANY, AUSTRALIA, AND THE UK
Increasingly, global cannabis markets are moving toward regulated operations and have much to teach each other. Regulators around the world...
Read more
Cannabis Biotech: Charting the Future of Scientific Discovery
Michael Sassano, the Founder of SOMAÍ Pharmaceuticals, discusses the latest advancements in cannabis biotechnology and explores the opportunities and challenges...
Read more
SOMAÍ Pharmaceuticals Signs Supply Contract with Cosma Cannabis
SOMAÍ Pharmaceuticals has entered into a two-year supply agreement with a well-respected Polish distributor Cosma Cannabis. Cosma produces medical-grade cannabis...
Read more
May 2023
SOMAÍ has been highly active as we continue to make significant strides toward our highly anticipated product launch scheduled for...
Read more
Global Whispers: A global market access journey in cannabinoid pharmaceuticals
Michael shares his company’s experiences bringing new products to market, the challenges SOMAÍ Pharmaceuticals have faced and the lessons the...
Read more
April 2023
SOMAÍ has had another thrilling and eventful month as we approach our product launch in the second half of 2023.Firstly,...
Read more
Who Was The Winner With German Recreational Light? Pharmaceutical Cannabis
Germany has finally come out with their proposed regulation, and the clear winner is pharmaceutical EU-GMP cultivators and manufacturers. April...
Read more
GMP# 18: Sales Planning for Pharmaceutical GMP Facilities
All startups, including new pharmaceutical manufacturing facilities, need to grapple with the complexities of launching. Pharmaceutical products are a considerable...
Read more
March 2023
SOMAÍ has had another thrilling and eventful month as we approach the launch of our first products in just a...
Read more
Listen Up, Startups Episode 11: Next Generation Biotech with Michael Sassano
Humanity's healthcare needs are evolving faster than most of us can keep up with. And while many seem to be...
Read more
Michael Sassano & Antonio Guedelha: GMP# 17: GMP Market Forecasting and Budget Management
Read more
Why North American medical cannabis can’t compete globally
Read more
European Cannabis Q4 2022 Quarterly Update
Read more
Medicinal cannabis: Why more clinical trials and better access is needed
Read more
Interview with Michael Sassano
Read more
What start-ups can learn from highly regulated industries
Read more
Europe’s booming cannabis industry
Read more
A Very Unhappy Christmas
Read more
High prices, beating the black market, lack of education: “The European cannabis market has a long way to go”
Read more
Michael Sassano & Antonio Guedelha: GMP # 16 – Waste Reduction Management in Good Manufacturing Practice
Read more
Pharmaceutical Cannabis and The Influence From Big Pharma – Grassroots Marketing
Read more
International Cannabis Reform Ramps Up in Europe, South America
Read more
An entrepreneur’s guide to the recreational cannabis market in Europe
Read more
Michael Sassano & Antonio Guedelha: GMP #15 – Quality Control Laboratory Optimization in GMP
Read more
Glassroots Marketing Podcast: Pharmaceutical Cannabis and The Influence From Big Pharma
Grassroots Marketing discusses Pharmaceutical Cannabis and The Influence From Big Pharma with Michael Sassano, CEO of Somai Pharmaceuticals. Michael is the CEO...
Read more
The Right Way to Start A European Cannabis Business
Read more
International Cannabis Reform Ramps Up in Europe, South America
Read more
Michael Sassano & Antonio Guedelha: GMP #14 Client Management in GMP
Read more
Green Peak Podcast: Somai Pharmaceuticals LTD With Michael Sassano
Michael Sassano is one of the original movers and shakers in the cannabis industry. He was an early investor in...
Read more
Somai Pharmaceuticals LTD With Michael Sassano – The Green Peak Podcast hosted by Richard Zwicky
Read more
7 Ways to Increase Terpene Levels in Cannabis
Read more
Germany’s Move To Legalize Marijuana Will Spark A Wildfire In Europe, Says This Cannabis CEO
Read more
Germany’s Move to Legalize Marijuana Will Spark a Wildfire In Europe: Mike Sassano
Read more
Germany recreational cannabis winners and losers
Read more
42_Watch Out. Europe Is Gaining Ground Over The U.S. In Cannabis Medicine
Listen to Michael Sassano who is one of the most respected executives in the pharmaceutical cannabis space today. He was...
Read more
European Cannabis Q3 2022 Quarterly Update
Read more
Is It Really Hard To Start A Business When You’re Over 50?
Read more
Do Any States Face The Risk Of A Dominant Cannabis Market Operator?
Read more
CBD Health Podcast Episode #47- Listen to Michael Sassano who’s the international cannabis industry leader
Read more
Let’s be Blunt with Montel – INTERNATIONAL CANNA | MICHAEL SASSANO
Read more
Michael Sassano Exclusive Interview With TheCelebrity.Online
Read more
Cannabis Crossing Borders: Global Flower Trade in 2022
Read more
SOMAÍ Pharmaceuticals Opens Portugal Manufacturing Facility
Read more
The Mary Jane Society Podcast – Watch Out. Europe Is Gaining Ground Over The U.S. In Cannabis Medicine
Read more
Schumer is still committed to cannabis banking reform
Read more
Germany’s Adult Use Cannabis Laws Steeped In Optimism And Uncertainty At The Moment
Read more
To Be Blunt: The Professional Cannabis Business Podcast – Episode 117: The Global Cannabis Market and Why Germany is Poised to Lead
Read more
The Investor Talk – with Michael Sassano, CEO and Chairman for SOMAÍ Pharmaceuticals
Read more
Inside Europe’s largest cannabis manufacturing facility
Read more
Making the Best Concentrates For a Global Market
Read more
Michael Sassano & Antonio Guedelha: GMP #13: Preventive Maintenance in GMP
Read more
Michael Sassano of Somai Pharmaceuticals on To Be Blunt – Episode 117 The Global Cannabis Market and Why Germany is Poised to Lead
Read more
Karma Koala Podcast Episode 92: Professor June McLaughlin, Kim Stuck Allay Consulting, Michael Sassano Somai Pharmaceuticals & Amy McDougal Clearsources
Read more
Interview Time! Michael Sassano – CEO of Somai Pharmaceuticals
Read more
With Extracts Expected To Achieve A ‘50% Share Of The EU Cannabis Market’ In The Next Few Years, Who Is Currently Leading The Field?
Read more
The Case for THCA and Other Minor Cannabinoids
Read more
Consider Cannabis – Cannabis and International Markets
Read more
Michael Sassano & Antonio Guedelha: GMP #12: Optimizing Pharmaceutical Good Manufacturing Processes
Read more
SOMAÍ PHARMACEUTICALS – MEDICAL CANNABIS PRODUCTS MANUFACTURING FACILITY
Read more
Here Weed Go – It’s Pharmaceutical (in Europe)
Read more
The Israeli Cannabis Market Is Growing Faster than People Realize
Read more
European Cannabis Regulators Ease Restrictions in Preparation of EU Green Wave
Read more
Vertical Integration: Cannabis Experts Discuss Its Various Pros And Cons
Read more
ICBC Berlin 2022 B2B Conference Panels Day 2 | Cannabis In Biotechnology
Read more
Disposable Vapes Are An Environmental Concern But Producers Won’t Stop Making ’til You Stop Buying
Read more
European Cannabis Q2 2022 Quarterly Update
Read more
SAFE Banking Act Dropped From China Competition Bill
Read more
Switzerland Removes Medical Marijuana Access Limitations As Demand Rises
Read more
Switzerland set to lift medical cannabis restrictions
Read more
Cannabis Insiders Split On Market Impact Of Inflation
Read more
Thailand removes cannabis from narcotics list, decriminalises growing plants at home
Read more
Germany’s legalisation push has lit up the European cannabis market
Read more
Michael Sassano & Antonio Guedelha: GMP #11: Stock Management in GMP Manufacturing
Read more
The Cannabis Corner Episode 44 – Michael Sassano, CEO and Chairman for Somai Pharmaceuticals
Read more
Sequire Cannabis & Psychedelic Conference 2022 – Somai Pharmaceuticals
Read more
CannaList Conversations with Michael Sassano, CEO and Chairman for Somai Pharmaceuticals
Read more
“Positive shock waves”: Germany accelerates process for cannabis legalisation
Read more
CPhI North America 2022: Pharmaceutical Cannabis Global Marketplace
Read more
Michael Sassano & Antonio Guedelha: GMP Article 10: Production Cost Calculation Systems in GMP
Read more
MGC Pharma, Cansativa Group & Somai Pharmaceuticals announced among Cannabis Europa sponsors
Read more
European Cannabis Q1 2022 Quarterly Update
Read more
How to Invest in Marijuana
Read more
Michael Sassano: GMP Article No 9: Bringing New Products to GMP Facility
Read more
The European Cannabis Report: 7th Edition | Expert Opinions: Michael Sassano (page 34)
Read more
3 Reasons Cannabis Sin Stocks Stay Strong in Volatile Markets
Read more
Inflation: is it affecting the cannabis market?
Read more
The case for improving absorption for cannabinoids using ethosomes
Read more
Opinion: 2022 could be the year for pharmaceutical marijuana
Read more
SOMAÍ Pharmaceuticals + Huge Gage Cannabis News!
Read more
Karma Koala Podcast Episode 67: This Week Michael Sassano, Inesa Ponomariovaite & Our Regular Segment From Dentons German Cannabis Head, Peter Homberg
Read more
Innovations in Dosing Technologies: Getting an Accurate Hit, Every Time
Read more
Safety and Culture at Forefront of Cannabis Social Club vs. Dispensary Debate
Read more
Synthetic Cannabinoids versus Plant-Derived Products
Read more
Spotlight Interview with Michael Sassano, CEO and Chairman of the Board for Somai Pharmaceuticals
Read more
How Germany Can Enter The Adult-Use Cannabis Market Successfully
Read more
How Germany Can Enter The Adult-Use Cannabis Market Successfully
Read more
Portugal Is Highly Likely To Legalize Recreational Cannabis
Read more
Michael Sassano – Somai Pharmaceuticals – Conforming to the Highest Pharmaceutical Standards
Read more
Uber Eats to Offer “Baked Goods” with Canadian Cannabis Partnership
Read more
Croptober – Navigating the Business of Cannabis Cultivation and Sustainability – Michael Sassano
Read more
Cannabis Europa London 2021 – Michael Sassano
Read more
Which Countries Will Likely Legalize Cannabis In 2022 And Why Isn’t The US Among Them?
Read more
Michael Sassano, Renowned Pharmaceutical Expert, and Founder and CEO of Somai Pharmaceuticals LTD Zoom Interviewed
Read more
DotCom Magazine Interview of Michael Sassano, CEO & Founder of Somai Pharmaceuticals LTD
Read more
How SOMAÍ is Bringing ‘Peak Efficiency’ and ‘Peak Profitability’ to the European Cannabis Market
Read more
Cannabis Investment: 7 Best Marijuana Stocks to Buy for 2022
Read more
Michael Sassano: GMP Series #8: Manufacturing Startup
Read more
Few Medical Cannabis Licenses in Portugal Have Been Awarded
Read more
Cannabis Co. Receives $3M ‘Innovative Products’ Grant From Government, EU In Portugal
Read more
SOMAÍ Pharmaceuticals awarded €2.7M in funding from Portugal 2020 Grant
Read more
Projeto Nº POCI-02-0853-FEDER-179647
Read more
EU: Cannabis company receives €2.7 million grant
Read more
SOMAÍ Pharmaceuticals Erhält Im Rahmen Von Portugal 2020 Fördermittel In Höhe Von 2,7 Mio. Euro
Read more
SOMAÍ Pharmaceuticals bénéficie d’un financement de 2,7 millions d’euros de Portugal 2020
Read more
Somai Pharmaceuticals: SOMAÍ Pharmaceuticals erhält im Rahmen von Portugal 2020 Fördermittel in Höhe von 2,7 Mio. Euro
Read more
SOMAÍ Pharmaceuticals awarded €2.7M in funding from Portugal 2020 Grant
Read more
SOMAÍ Pharmaceuticals awarded €2.7M in funding from Portugal 2020 Grant
Read more
SOMAÍ Pharmaceuticals awarded €2.7M in funding from Portugal 2020 Grant
Read more
SOMAÍ Pharmaceuticals awarded €2.7M in funding from Portugal 2020 Grant
Read more
SOMAÍ Pharmaceuticals bénéficie d’un financement de 2,7 millions d’euros de Portugal 2020
Read more
Somai: The Global Story of Cannabis
Read more
SOMAÍ Pharmaceuticals at MJUnpacked: What Are You Trying To Accomplish At MJ Unpacked?
Read more
SOMAÍ Pharmaceuticals at MJUnpacked: What Markets And Geography Does Somai Pharma Address?
Read more
SOMAÍ Pharmaceuticals at MJUnpacked: What Should Consumers, Other Brands And Investors Know About The Future Of Somai Pharma
Read more
SOMAÍ Pharmaceuticals at MJUnpacked: Tell Us About Your Company And What Makes You Different
Read more
These Are The Cannabis Industry’s Biggest Tricks and Treats So Far
Read more
Michael Sassano: GMP Series #7: Personnel Recruitment
Read more
Michael Sassano: GMP Series Part 6 – Quality Assurance Implementation
Read more
Why Germany is Not the Future Leader of European Cannabis
Read more
Michael Sassano CEO and Chairman Somai Pharmaceuticals: GMP Series #5: ERP Implementations
Read more
The Advantages of Ethanol Extraction
Read more
Does Big Business Provide A Better Look Into Cannabis Reform Than Capitol Hill?
Read more
Does Big Business Provide A Better Look Into Cannabis Reform Than Capitol Hill?
Read more
Does Big Business Provide A Better Look Into Cannabis Reform Than Capitol Hill? Operators Believe So.
Read more
Cannabis Stocks Next Big Wave Is Coming Late August
Read more
Michael Sassano and Antonio Guedelha: GMP Series Part 4: Laboratory Set-Up
Read more
GMP Series Part 3: Process Equipment Procurement
Read more
Could Drug Store Giants Eventually Sell THC? It’s Possible, But Many Hurdles Remain
Read more
European Cannabis is Starting to Look Like the US Market 10 Years Ago
Read more
CANNA WORLD EXPO EUROPEAN UPDATE SOMAI PHARMACEUTICALS CEO MICHAEL SASSANO
Read more
Expert Interview: Michael Sassano, CEO Somai Pharmaceuticals
Read more
Beyond CBD, THC: ‘Minor’ Cannabinoids Flood Market — Lack of data is concerning, even for practitioners who believe in medical cannabis
Read more
Why GMP is the Future of Quality Control for the Global Industry
Read more
SOMAÍ Pharmaceuticals Bringing The Future Of European Cannabis Market
Read more
SOMAÍ Pharmaceuticals Bringing The Future Of European Cannabis Market
Read more
Morocco: Cannabis Legislation but the Devil in the Details
Read more
Low-Cost Pot Stocks To Consider, According To SOMAÍ Pharmaceuticals CEO Mike Sassano
Read more
Cannabis Revival and Year of the SPAC’s: What’s To Be Expected the Rest of 2021?
Read more
SPAC Mania: The Biggest Cannabis Boom Is Yet To Come
Read more
GMP Series Part 2: Building and Design – Authored By: Michael Sassano and Antonio Guedelha
Read more
Benzinga Cannabis Capital Conference | February 25-26, 2021 | Michael Sassano
Read more
Navigating Regulatory Hurdles in Specific Countries
Read more
Cannabiz: How to Invest in This Growing Industry
Read more
GMP & Compliance: GMP SERIES #1: “Starting Your GMP Approval Process for Cannabis Correctly”
Read more
PREDICTIONS | Want to know the future? There are two ways: a crystal ball or really smart people (pages 74-75)
Read more
Ingenious Cannabis Entrepreneurs to watch in 2021
Read more
These Are The Top European Cannabis Companies
Read more
9 Things to Consider When Raising Capital for Startups in Europe
Read more
Tantalizing Terpenes Boost Cannabinoid Blends For The European Market (pages 20-21)
Read more
UK to see largest medical cannabis market growth in Europe 2020 to 2025
Read more
Desert Oasis | Solaris Farms is capitalizing on a prime location and plenty of Nevada sunshine (page 58-61 November issue)
Read more
‘The sweet spot for cannabis business opportunities is somewhere between medical and recreational’ – experts explain how to find it
Read more
Cannabis Top 20: North America’s Largest Commercial Grows
Read more
Real Deals – Michael Sassano
Read more
Best practices for securing your cannabis grow operations and supply chains
Read more
Cannabis Terpenes: What Growers Need to Know
Read more
Opening the Pot: Vegas Cannabis Industry Moving Ahead Amidst COVID
Read more
California joins push to let cannabis businesses use banks as part of coronavirus relief
Read more
Cannabis company executives speak to the industry’s trying times
Read more
Why Large-scale cannabis producers are turning to Hybrid Greenhouses
Read more
Lawmakers Look to Include Cannabis Banking Reform in Next COVID-19 Stimulus Bill
Read more
COVID-19 Is Leaving Its Mark On The Cannabis Industry, Insiders Say
Read more
Why Cannabis Will Boom During the “New Normal”
Read more
Cannabis Do-Gooders: These Companies Are Lending A Helping Hand Against COVID-19
Read more
Cannabis Do-Gooders: These Companies Are Lending A Helping Hand Against COVID-19
Read more
Hemp Companies Step Up To Help During Pandemic
Read more
Cannabis Pros Sound Off On How Coronavirus Pandemic Will Affect Industry
Read more
CannaBusiness Tips For Coronavirus Times
Read more
Cannabis Executives on Turbulent Markets: “Don’t Panic”
Read more
Michael Sassano: the man bringing US cannabis know-how to Europe
Read more
Michael Sassano: the man bringing US cannabis know-how to Europe
Read more
Michael Sassano: the man bringing US cannabis know-how to Europe
Read more
New Cannabis Products: Kiva’s Camino CBN Line, Solaris x Cannabis & Culture’s Line And A Topical Cream
Read more
New Cannabis Products: Kiva’s Camino CBN Line, Solaris x Cannabis & Culture’s Line And A Topical Cream
Read more
European Union Urges Member Nations to Vote for World Health Organization’s Cannabis Rescheduling Recommendations
Read more
“Marijuana is a global trend that can no longer be stopped.”
Read more
Which European Countries Cannabis Investors Should Watch in the New Decade
Read more
Solaris Farms & Tech-Driven Growing
Read more
‘Big Cannabis’ Technologically Ahead Of Its Times, But Post-Harvest Automation Remains Elusive
Read more
U.S. leads in cannabis innovation, but cedes global market to Canada
Read more
American pot is the gold standard. But Canada leads the export game — for now
Read more
American pot is the gold standard. But Canada leads the export game — for now
Read more
From Seed to Sale Nevada’s Cash Crop Cannabis Industry
Read more
America’s marijuana growers are the best in the world, but federal laws are keeping them out of global markets
Read more
What Should Investors Take Away From MJBizCon 2019?
Read more
How to Do Cannabis Cultivation Business Planning for Growth
Read more
“5 Things I Wish Someone Told Me Before I Started Leading a Cannabis Business”, with Michael Sassano and Len Giancola
Read more
Key trends when investing in the Cannabis industry in Opportunity Zones
Read more
Vegas Hybrid GreenHouse Dominance by Mike Sassano – page 20
Read more
The Cannabis Cultivation Costs by State
Read more
Mike Sassano: Increasing Potency with Greenhouse Technology
Read more
OZ WRITERS COUNCIL DIRECTORY
Read more
Are cannabis hand-trimmers an endangered species?
Read more
Automation and sensors in hybrid greenhouses
Read more
Desert Greenhouse Cultivation
Read more
Five Diverse Questions With Michael Sassano, Founder: Solaris Farms
Read more
Automation is the Future of Cannabis
Read more
How Solaris Farms’ Michael Sassano Works: Cannabis Workspace
Read more
Federal Court Orders DEA to Explain Inaction on Cannabis Cultivation Applications
Read more
Federal Court Orders DEA to Explain Why It Has Ignored Cannabis Cultivation Applications
Read more
Soma Pharmaceuticals Reveals Plans for Ireland’s Medical Cannabis Market
Read more
What Technology Will Most Impact The Cannabis Industry? 24 Experts Share Their Insights
Read more
Solaris Farms Tackles Desert Heat with Global Tech
Read more
What Trends Are Shaping The Cannabis Industry In 2019? 25 Experts Weigh In
Read more
What’s The Future Of The Cannabis Industry? 28 Experts Share Their Perspectives
Read more
CANNABIS INTERVIEW – MICHAEL SASSANO – FOUNDER SOLARIS FARMS
Read more
Mike Sassano – A Cannabis Business in the Opportunity Zone
Read more
Define “Organic”: The Cannabis Movement Is Stuck On Labeling
Read more
SOMAÍ Partners with SHERBINSKIS and BOUTIQ
A New Era for Medical Cannabis: SOMAÍ Teams Up with Iconic California Brands SHERBINSKIS and BOUTIQ for Europe and Australia...
Read more
Ireland Could Make Great Cannabis Policy: Examining the Past to Look Forward
Access to safe and controlled cannabis for the Irish people is being decided upon in 2025. Watching a country make...
Read more
Product Dumping, White Labels, and Conflicts of Interest Lead to Global Cannabis Price Catastrophe
2025 has kicked off fast and furious for the global cannabis industry as volumes increase and more countries come online...
Read more
The Rise of Multi-Country Operators: Somai Targets 20 Countries by Year End
Multi-state operators, or MSO’s, have long represented the biggest and most influential cannabis players in North America. Yet, as that...
Read more
The Shift Toward Recognised Brands in Medical Cannabis
For years, medical cannabis has been treated as a commodity, with little emphasis on brand differentiation. However, as the market...
Read more
Eyes on Thailand in the Global Medical Cannabis Scene: SOMAÍ and Cali Dior Lead the Revolution
Global medical cannabis markets are exploding, and the patients exploring cannabis as an alternative therapy are more diverse than ever....
Read more
Q4 2024: Global Medical Cannabis Continues To Soar
The global cannabis industry saw an incredible end to 2024. Q4 2024 showed that the international medical cannabis explosion is...
Read more
SOMAÍ Joins Forces with Dascoli to Advance Swiss Medical Cannabis Market
Expanding its global footprint, SOMAÍ continues its European growth with a Swiss market entry through a strategic partnership with Dascoli...
Read more
The lobsterpot podcast S.4 EP. 1 wih Michael Sassano
SOMAÍ’s CEO, Michael Sassan, joins The Lobsterpot Podcast for an in-depth conversation on the future of Europe’s cannabis markets as...
Read more
U.S.-style cannabis dispensaries are sweeping global medical markets
Medical cannabis markets around the world are starting to show signs of early United States and Canadian-style progressions. Consumer flower...
Read more
2025 Cannabis Predictions: The Global Medical Cannabis Explosion Continues
2025 is poised for a massive explosion in the global medical cannabis market. Many politicians and regulators have been grappling...
Read more
SOMAÍ Pharmaceuticals and PACCAN Join Forces to Transform Medicinal Cannabis in Asia and Beyond
SOMAÍ Pharmaceuticals partnered with Pacific Cannovation Company Limited (PACCAN) to transform Thailand into a global hub for high-quality medicinal cannabis...
Read more
SOMAÍ Pharmaceuticals Redefines Patients Experience with the Launch of Origins and Senses Lines
SOMAÍ Pharmaceuticals, a leading EU-GMP vertically integrated Multi-Country Operator (MCO) company, proudly announces the global launch of its Origins and...
Read more
Portugal em Direto – Maior Empresa Da Europa Está Em Portugal
RTP1 - Portugal em Direto about SOMAÍ Pharmaceuticals
Read more
Portugal é o “epicentro do cultivo e produção de canábis”, revela CEO da SOMAÍ Pharmaceuticals
Com uma das maiores infraestruturas para cultivo e produção de canábis, Portugal é o maior exportador europeu desta planta para...
Read more
Cannabis industry predictions 2025: Market trends
Although new states continue to implement medical and adult-use cannabis programs, sales have been declining in the early adopters of...
Read more
The Grünhorn and Canymed Edge: Introducing Germany to SOMAÍ Extracts
Germany is one of the fastest-growing global medical cannabis markets. Recent changes in cannabis legislation have allowed doctors to more...
Read more
Business of Cannabis: Podcast | Releaf x SOMAÍ Pharmaceuticals
Releaf Clinic and SOMAÍ Pharmaceuticals have joined forces to provide UK patients with the largest portfolio of cannabis-based medicinal products...
Read more
2025 Czechia Cannabis Predictions from Cannafest
Czechia has a population of roughly 11 million people, and cannabis has been decriminalized since 2010. As one of the earliest...
Read more
Público: Michael trouxe a experiência da cannabis medicinal do Nevada para o Carregado
Portugal já exportou este ano quase 19 toneladas de cannabis, sobretudo para a Alemanha. Em Outubro, existiam 37 entidades licenciadas...
Read more
Compounding the Issue: Germany’s Medical Cannabis Market Needs a New Approach
Germany has some of the most progressive cannabis rules in the global markets. The cannabis industry is celebrating decriminalization, which provides...
Read more
Michael Sassano: Spain finally opens access to medical cannabis
After three years of political delays, Spain has taken a big step toward starting what it promised in terms of...
Read more
The Good, the Bad, and the Profitable: Inside Germany’s EU-Leading Medical Cannabis Industry
The growth of the German medical cannabis market is poised to be highly profitable for the country. One billion euros...
Read more
The AusCannaPodcast S2 | E8 with Michael Sassano
In this episode of the AusCannaPodcast, Christina Mc Mullan sits down with Michael Sassano, CEO and Chairman of SOMAI Pharmaceuticals,...
Read more
Poland’s Path to Cannabis: Two Companies Meeting Market Demands
Poland is the fastest-growing new cannabis market in the entire global medical space. Not only is the extracts market growing...
Read more
SOMAÍ Pharmaceuticals e Universidade Lusófona colaboram em publicação científica sobre o efeito ‘entourage’
A indústria da canábis medicinal continua a evoluir, com a investigação a abrir caminho para aplicações terapêuticas inovadoras. A SOMAÍ Pharmaceuticals,...
Read more
Two Cannabis Vertical Powerhouses Partner to Optimize Patient Experience
When two great companies pair to create the best patient experience possible, the global CBPM industry must take notes. Ultimately,...
Read more
Michael Sassano: “Portugal is the epicentre of cannabis cultivation and production. This is a place that will thrive”
Michael Sassano’s main goal at SOMAÍ is to produce the most advanced products with the most innovative administration routes, to...
Read more
European Cannabis Q3 2024 Quarterly Update
“WOW” is the only word to describe the excitement buzzing around the European cannabis community. The cannabis markets in Europe...
Read more
Impairment Vs Presence Of Cannabis: The International Cannabis Driving Debate Continues
Around the world, the debate continues about how to quantify the presence of cannabis in an individual’s system and how...
Read more
Give and Toke: Excitement in Global Markets w/ Michael Sassano (SOMAÍ Pharmaceuticals)
Listen to the latest episode of the Give and Toke podcast, which elevates the conversation about cannabis to a higher...
Read more
Drug Science: What is the UK medical cannabis industry looking like in 2024?
We are 6 years on from legalisation of cannabis-based medical products in the UK and although many patients have now...
Read more
EU Medical Cannabis Meets Recreational Choice: A New Era in European Preference
Europe has been one of the most interesting cannabis markets to watch develop: What was a pure medical cannabis market has...
Read more
SOMAÍ Pharmaceuticals Announces Partnership with Releaf Clinic to Bring Innovative Cannabis Solutions to UK Patients
This collaboration marks the synergy of two vertically integrated fast-growing companies. SOMAÍ Pharmaceuticals is proud to announce a strategic partnership...
Read more
Innovations in Cannabis Extracts Entice New Demographics
Interesting trends emerge when we examine the largest extract markets in the global cannabis industry. These trends suggest that innovations...
Read more
SOMAÍ Pharmaceuticals Launches in Ireland, Offering the Broadest Range of Cannabis-Based Medicines to Patients
SOMAÍ Pharmaceuticals ("SOMAÍ"), a leading EU-GMP vertically integrated Multi-Country Operator (MCO) company with a global footprint of distribution for the...
Read more
What Does the Future Hold for UK Cannabis?
After a recent conversation with Pierre van Weperen of Grow Group PLC and Grow Pharma, his vision of the United Kingdom’s...
Read more
EU verticals create new European MCOs: Multi-Country Operators
New European MCOs: Multi-Country Operators European cannabis markets are heating up, and virtually every country is buzzing about regulatory change...
Read more
The Best Global Cannabis Markets By Country 2023-2024
The global cannabis universe continues to expand rapidly after the United States Department of Health and Human Services (HHS) report, Germany’s removal...
Read more
Global Cannabis: Michael Sassano, CEO and Founder at Somai Pharmaceuticals (AltMed Ep.117)
Watch the latest AltMed podcast, in which Michael Sassano and Andrew Dowling, AltMed's co-founder, discuss different aspects of the global...
Read more
The battle for Australian-grown cannabis: quality vs global price wars
There is a buzz around Australia about “Made in Australia” products, including cannabis. Every country should be proud of its...
Read more
Cosma S.A. and SOMAÍ Pharmaceuticals partner to Revolutionize Poland with the most Innovative Cannabis-Based Solutions
LISBON, PORTUGAL, August 29, 2024 - Cosma S.A., a leader in cannabis-based pharmaceutical advancements, and SOMAÍ Pharmaceuticals, a fully vertically...
Read more
Hanf Journal: Interview mit Michael Sassano, CEO von SOMAÍ Pharmaceuticals
Cannabis-Extrakte haben sich als vielversprechendes Therapeutikum in der modernen Medizin etabliert. Allerdings werden viele Anwenderinnen und Anwender vom Geschmack abgeschreckt,...
Read more
ICBC News: Legal Global Cannabis Products Are Becoming More Diverse
As the legal cannabis industry continues to expand to nearly every corner of the planet, the variety of products available...
Read more
What is Spain’s New Medical Cannabis Regulatory Framework?
Ultimately, patients deserve access to safer alternatives to current over-prescribed pharmaceutical medicines. Spain has become the latest large European country...
Read more
2024’s Hottest Global Medical Cannabis Market Trends
A massive dose of energy has jolted the global cannabis markets. The United States Department of Health and Human Services (HHS)...
Read more
European Cannabis Q2 2024 Quarterly Update
2024’s second quarter transpired strongly and predictably after the positive news of the 252-page United States Department of Health and Human...
Read more
CannaReporter: SOMAÍ’s Journey to Global Leadership in Cannabinoid Extracts
SOMAÍ Pharmaceuticals is a leading EU-GMP European vertically integrated Multi-Country Operator (MCO) company with a global footprint of distribution for...
Read more
Sassano: Why future EU medical cannabis branding is essential
Michael Sassano is a CEO and Chairman of the Board for SOMAÍ Pharmaceuticals, a leading EU-GMP European pharmaceutical and biotech...
Read more
SOMAÍ Pharmaceuticals Expands Its Most Comprehensive Medicinal Cannabis Portfolio With Launch of New Mint Oral Solutions Line
SOMAÍ Pharmaceuticals ("SOMAÍ"), a fully vertically integrated Multi-Country Operator (MCO) in the global medical cannabis markets, is proud to announce...
Read more
Financial Times: European cannabis companies start IPO planning as US considers looser rules
A number of European cannabis start-ups are planning to go public in New York to take advantage of a US...
Read more
Put Some Mint Terpenes In It
What is the first thing you do when you open a new bag of cannabis flower? You smell it! Cannabis...
Read more
Cannabiz: SOMAÍ Pharmaceuticals ‘keeps promise’ to deliver expanded product range
SOMAÍ Pharmaceuticals is rolling out a suite of new products in Australia as it aims to back up its pledge...
Read more
Germany Leads The Global Medical Cannabis Explosion
The entire cannabis community is abuzz with German legalization. Not only is this a massive windfall for cannabis producers around the...
Read more
A Comparison Of Legal And Illicit EU Cannabis Markets
Co-Authored by Michael Sassano and Callum Kellas The cannabis illicit market existed in all countries long before the legal markets...
Read more
Pillar 2: German Cannabis Legalization is Moving Forward Fast
As if 2024 didn’t give the global medical cannabis enough with a 252-page report from the United States Department of Health and...
Read more
European Cannabis Q1 2024 Quarterly Update
2024 ushered in one of the most reformatory changes that the global medical cannabis community has ever witnessed. The EU...
Read more
Business of Cannabis: Breaking Down Barriers to Medical Cannabis in the UK
UK medical cannabis patients are facing multiple challenges that are preventing the adoption of the legal market. From stigmatisation and...
Read more
Medical Cannabis Goes Global: Michael Sassano of SOMAÍ reflects on UK launch (GC S2E7)
https://www.youtube.com/watch?v=tObqvfLA5lo&t=9s&ab_channel=GrowConversations Discussing a range of topics, including Michaels's background in setting up medical cannabis cultivation facilities in the US, The...
Read more
Leading Canadian Cannabis Brand Ghost Drops Enters into an Agreement with SOMAÍ Group for Global Distribution
The partnership opportunely positions Ghost Drops and SOMAÍ Group to succeed in the EU, UK, and Australian Cannabis Markets LISBON,...
Read more
SOMAÍ Group, and its subsidiary, RPK Biopharma expand Cookies partnership to include Europe and the UK
SOMAÍ Group ("SOMAÍ") and its subsidiary, RPK Biopharma expanded their existing partnership with Cookies Creative Consulting & Promotions, Inc., a...
Read more
Cannabis Rescheduling: DEA’s Decision Marks a New Era for the Industry
The US Drug Enforcement Administration (DEA) is set to approve the rescheduling of cannabis in a move set to have...
Read more
The Medical Cannabis Explosion Just Got Real
The global cannabis trifecta has hit! The United States has finally rescheduled cannabis, moving it to Schedule III; the Department...
Read more
EU STARTUP NEWS: Reshaping EU’s Biopharma Industry: Is Cannabis the Future of Pharmaceutical Treatments?
While the boundaries of pharmaceuticals continue to expand with cutting-edge innovations, Lisbon-based company SOMAÍ Pharmaceuticals is trailblazing in the field...
Read more
Euronews: Portugal grows tonnes of medical cannabis for export but it remains out of reach for local patients
“We’re a global company and as countries develop, we plug into that. We are still waiting for Portugal but it's...
Read more
Japanese Cannabis Reform Is Almost Here
In November 2023, the Japanese Ministry of Health, Labor and Welfare (MHLW) was tasked with developing rules and standards for THC levels...
Read more
Assessing Thailand’s Massive Cannabis Market Reality
The Thai cannabis market is currently a full-blown recreational model, and it has exploded quicker than any market in legal...
Read more
The Global Medical Cannabis Explosion Is Coming
Based in Lisbon, Portugal, Somai Pharmaceuticals is a large-scale, GMP-certified manufacturer and global supplier of cannabis products used in pharmacological...
Read more
When it comes to access, the rest of the world should follow Australia’s example
The Australian medical cannabis industry may have its challenges, but its focus on affordable access and patient care make it...
Read more
The Surging Tides Of Global Medical Cannabis Markets
You may not see it or even hear about it but have no doubts: an enormous regulatory framework tsunami pushing...
Read more
SOMAÍ Pharmaceuticals Introduces UK to The Most Complete Cannabis-Based Product Portfolio Following a Distribution Deal
SOMAÍ Pharmaceuticals Signs Distribution Deal with Grow Pharma for UK’s Most Comprehensive Range of Cannabis-Based Medicines LISBON, PORTUGAL, March 12,...
Read more
SOMAÍ Pharmaceuticals brings innovative product portfolio to Australia
European medicinal cannabis manufacturing powerhouse SOMAÍ Pharmaceuticals is set to shake up the Australian market with a range of products...
Read more
SOMAÍ Pharmaceuticals brings innovative product portfolio to Australia
European medicinal cannabis manufacturing powerhouse SOMAÍ Pharmaceuticals is set to shake up the Australian market with a range of products...
Read more
Ukraine joins global cannabis community
Now that Ukrainian President Volodymyr Zelenskiy has signed a law opening access to medical cannabis, Ukraine has joined a list of...
Read more
European Cannabis Q4 2023 Quarterly Update
U.S. and German Events Steer International Cannabis in 2024 As 2023 ended, all eyes remained glued on the United States Schedule...
Read more
Don’t get caught on the hop by HLVd
As Hop Latent Viroid is discovered in Australian cannabis crops for the first time, SOMAÍ Pharmaceuticals founder, chairman, and CEO Michael Sassano shares advice...
Read more
SOMAÍ Pharmaceuticals Acquires RPK Biopharma (Holigen), Reinforcing Global Leading Position in Medicinal Cannabis Sector
This strategic acquisition enhances SOMAÍ's capacity with best-in-class cultivation, manufacturing, and distribution assets, making it one of the few verticals...
Read more
The Global Medical Cannabis Explosion is Imminent
Recently, I have become more optimistic about the global landscape of medical cannabis and the direction in which major regulatory...
Read more
2024 New Global Emerging Cannabis Markets Predictions
"As the entire cannabis world is abuzz and cannabis stocks are shooting through the roof with the potential United States...
Read more
Good or bad taste will make or break your cannabis product
When it comes to creating the ultimate cannabis brand, it’s all a matter of taste, says SOMAÍ Pharmaceuticals founder, chairman,...
Read more
SOMAÍ Pharmaceuticals Introducing the U.S. Award-Winning Airo Brand to European and Australian Markets
SOMAÍ Pharmaceuticals announces its partnership with AIRO BRANDS, a U.S. multi-state CPG company focused on proprietary cannabis products. LISBON, PORTUGAL,...
Read more
The Mary Jane Society Podcast: Michael Sassano On Europe’s Cannabis Market
SOMAÍ Pharmaceutical‘s CEO Michael Sassano explores why the bill is a double edged sword, marking positive progress on one hand, but...
Read more
US Cannabis Rescheduling Primed to Set Off a Global Cannabis Explosion
Written by Michael Sassano, CEO, Somai Pharmaceuticals. Published in Business of Cannabis. On January 12, the United States Department of Health and...
Read more
Looking to expand overseas? Here’s what you need to know
Cannabis has long been trending as a global product, providing regional players with the chance to expand into international markets. Somai...
Read more
Why 2024 Will Be the Best Year Yet for Cannabis Investment
Year over year, global cannabis revenues exceed expectations and now stand at an estimated $50 billion in global sales in...
Read more
How Australian Cannabis Brands Can Enter Europe
Cannabis has long been trending as a global product, providing regional players opportunities to reach outside their home countries and...
Read more
Ukraine Makes ‘Historic Decision’ to Legalise Medical Cannabis
“Ukraine is headed towards cannabis legalisation which will align themselves next to German cannabis reform. As pivotal as Ukraine is...
Read more
Ukraine Lawmakers Vote to Legalize Medical Marijuana
Ukraine’s parliament voted today to legalize medical marijuana. This vote comes after the war with Russia left thousands of people...
Read more
Ukraine Lawmakers Vote To Legalize Medical Cannabis
“Ukraine legalizing cannabis should be a signal to all countries that prohibit medicinal cannabis, that there are much worst things...
Read more
The Future of European Medical Cannabis Dispensaries
As Switzerland opens up its first cannabis dispensary, cannabis pharmacies in the European Union need to pay attention and look...
Read more
SOMAÍ Pharmaceuticals and Canify Announce Their Partnership to Introduce a Cannabinoid-Based Product Line in Germany
SOMAÍ Pharmaceuticals and Canify AG announce their strategic partnership to introduce a differentiated cannabinoid-based product line in Germany LISBON, PORTUGAL,...
Read more
SOMAÍ Pharmaceuticals Enters German Market with Strategic Partnerships Securing €10 Million 2-year Distribution Deal
SOMAÍ Pharmaceuticals announces two significant partnerships with Canymed GmbH and Grünhorn, as part of its entry into the German market....
Read more
SOMAÍ Pharmaceuticals is thrilled to partner with the groundbreaking medical cannabis study, T21
Launched in 2019 by Drug Science, and now over 4000 patients in, T21 is building the scientific evidence base for...
Read more
3 main contributors to the entourage effect for cannabis consumers to consider
There is much talk surrounding the "entourage effect" in the cannabis world. The entourage effect is the proposed idea that...
Read more
SOMAÍ Pharmaceuticals Signs Manufacturing Contract with Canna Forest
SOMAÍ Pharmaceuticals has signed a manufacturing agreement with Canna Forest to produce EU-GMP-certified extracted cannabis APIs and products at its...
Read more
Q3 2023 European And US Cannabis Update
In the new edition of the "Q3 2023 European And US Cannabis Update," SOMAÍ Pharmaceuticals Founder and CEO Michael Sassano...
Read more
Four things to know for properly dosing oral cannabis formulations
As oral cannabis solutions become more popular, Michael Sassano CEO and founder of SOMAÍ Pharmaceuticals, explains how to get the...
Read more
Why white-labelled EU cannabis brands will fail
The European Union and global markets have invited the next cannabis disaster by disguising asset-poor brands as distributors and clinics....
Read more
SOMAÍ Pharmaceuticals Makes ‘Significant Step Towards Revenue Generation’ As Portuguese Market Heats Up
Last month, Portugal’s government announced plans to establish a working group to explore the regulation of adult-use cannabis, with a...
Read more
What is Medicinal cannabis
Read more
What are the key components of medicinal cannabis?
Read more
What is the story behind Medicinal cannabis?
Read more
The endocannabinoid system
Read more
How does the endocannabinoid system work?
Read more
SOMAÍ Pharmaceuticals: recent developments in the eyes of Michael Sassano
SOMAÍ Pharmaceuticals is a large-scale manufacturer of cannabis products, focusing on the highest quality medical-grade uses. They separate and purify...
Read more
Cannabinoids and the endocannabinoid system
Read more
What does the medicinal cannabis landscape look like today?
Read more
SOMAÍ Pharmaceuticals Receives EU-GMP Certification and Raises €5 million
SOMAÍ Pharmaceuticals Unipessoal LDA, the largest European pharmaceutical cannabis product manufacturer, is pleased to announce that it has received authorisation...
Read more
Crude FECO Vs Distillate Extracts: What Do Consumers Really Prefer?
Last week, Germany took the first step towards wholesale cannabis legalisation after the federal cabinet waved through the long-awaited draft...
Read more
Australian medical cannabis prioritises growing patient access
The Australian cannabis market is one of the largest, fastest-growing and most robust medical industries outside North America. Australia’s market...
Read more
How cannabis could help manage the unmet need in endometriosis
Endometriosis is a chronic inflammatory disorder that affects 10% of all women between the ages of 12 and 80 years...
Read more
Evolving legislature
Read more
Safety of medicinal cannabis and its side effects
Read more
What is Next After the German House Passes Cannabis Reform?
Last week, Germany took the first step towards wholesale cannabis legalisation after the federal cabinet waved through the long-awaited draft...
Read more
Europe’s current and future cannabis distribution models
Cannabis distribution companies in Germany and England received much attention and funding in early 2022. The growing revenue led investors to...
Read more
What are the barriers facing Spanish medical cannabis access?
Following another recent disappointment for Spanish patients, Michael Sassano, CEO and founder of SOMAÍ Pharmaceuticals explores the barriers preventing the...
Read more
From investor to innovator: Michael Sassano’s journey with SOMAÍ Pharmaceuticals
In a recent chat with Michael Sassano, the CEO of SOMAÍ Pharmaceuticals, we delved into the intricacies of the cannabis...
Read more
SOMAÍ Pharmaceuticals has renewed the partnership with Lusófona University/CBIOS for formulation development
According to this partnership, Lusófona will develop lab-scale formulations and perform corresponding stability testing. The collaboration will also encompass "In...
Read more
Albania Officially Green Lights Medical and Industrial Cannabis Cultivation
Albania has become the latest European country to officially legalise the ‘cultivation and processing of the cannabis plant and the...
Read more
European Cannabis Q2 2023 Quarterly Update
Country access schemes were simmering in the EU. Pressure continues to build from patients and advocates to increase access to...
Read more
WHAT IS THE CANNABIS EDGE IN GERMANY, AUSTRALIA, AND THE UK
Increasingly, global cannabis markets are moving toward regulated operations and have much to teach each other. Regulators around the world...
Read more
Cannabis Biotech: Charting the Future of Scientific Discovery
Michael Sassano, the Founder of SOMAÍ Pharmaceuticals, discusses the latest advancements in cannabis biotechnology and explores the opportunities and challenges...
Read more
SOMAÍ Pharmaceuticals Signs Supply Contract with Cosma Cannabis
SOMAÍ Pharmaceuticals has entered into a two-year supply agreement with a well-respected Polish distributor Cosma Cannabis. Cosma produces medical-grade cannabis...
Read more
May 2023
SOMAÍ has been highly active as we continue to make significant strides toward our highly anticipated product launch scheduled for...
Read more
Global Whispers: A global market access journey in cannabinoid pharmaceuticals
Michael shares his company’s experiences bringing new products to market, the challenges SOMAÍ Pharmaceuticals have faced and the lessons the...
Read more
April 2023
SOMAÍ has had another thrilling and eventful month as we approach our product launch in the second half of 2023.Firstly,...
Read more
Who Was The Winner With German Recreational Light? Pharmaceutical Cannabis
Germany has finally come out with their proposed regulation, and the clear winner is pharmaceutical EU-GMP cultivators and manufacturers. April...
Read more
GMP# 18: Sales Planning for Pharmaceutical GMP Facilities
All startups, including new pharmaceutical manufacturing facilities, need to grapple with the complexities of launching. Pharmaceutical products are a considerable...
Read more
March 2023
SOMAÍ has had another thrilling and eventful month as we approach the launch of our first products in just a...
Read more
Listen Up, Startups Episode 11: Next Generation Biotech with Michael Sassano
Humanity's healthcare needs are evolving faster than most of us can keep up with. And while many seem to be...
Read more
Michael Sassano & Antonio Guedelha: GMP# 17: GMP Market Forecasting and Budget Management
Read more
Why North American medical cannabis can’t compete globally
Read more
European Cannabis Q4 2022 Quarterly Update
Read more
Medicinal cannabis: Why more clinical trials and better access is needed
Read more
Interview with Michael Sassano
Read more
What start-ups can learn from highly regulated industries
Read more
Europe’s booming cannabis industry
Read more
A Very Unhappy Christmas
Read more
High prices, beating the black market, lack of education: “The European cannabis market has a long way to go”
Read more
Michael Sassano & Antonio Guedelha: GMP # 16 – Waste Reduction Management in Good Manufacturing Practice
Read more
Pharmaceutical Cannabis and The Influence From Big Pharma – Grassroots Marketing
Read more
International Cannabis Reform Ramps Up in Europe, South America
Read more
An entrepreneur’s guide to the recreational cannabis market in Europe
Read more